Abhishek Gowda, MD
Physical Medicine and Rehabilitation · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 7 carriers
- Offices
- 2
Offices
2 locations · Spine and Sports Medical Group Inc · County of San Mateo
Looking this up.
Hospitals listed: San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
25 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gowda’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A116395 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · University of Cincinnati College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$46,556
Medicare paid this office $46,556 for 99 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 70 | $28,546 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 25 | $4,399 | $126 |
| New patient visit (45+ min) | 24 | $3,806 | $159 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,982 | $58 |
| Injection of drug or substance under skin or into muscle | 22 | $669 | $14 |
See all 7 services
| Return visit (30+ min) | 70 | $28,546 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 25 | $4,399 | $126 |
| New patient visit (45+ min) | 24 | $3,806 | $159 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,982 | $58 |
| Injection of drug or substance under skin or into muscle | 22 | $669 | $14 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $594 | $46 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 16 | $0 | None |
Who their Medicare patients are
99 Original Medicare patients in 2024. Average age 74 · Women 65% · Also on Medicaid 38% · Health risk score 1.27. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 72% · Diabetes 35% · Coronary heart disease 27% · Chronic kidney disease 22% · Depression 18% · Atrial fibrillation 16% · Heart failure 15% · Cancer 14% · COPD 13% · Stroke 11%.
The office billed $834,374, Medicare allowed $61,406 and paid $46,556; for 651 services of 34 kinds; $84 of it was for drugs given in the office and $46,471 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 99 | 651 | 74 | 1.27 | $834,374 | $46,556 |
| 2023 | 86 | 512 | 74 | 1.26 | $552,202 | $41,456 |
| 2022 | 100 | 606 | 73 | 1.08 | $536,683 | $49,292 |
| 2021 | 101 | 664 | 72 | 1.09 | $565,311 | $52,341 |
| 2020 | 97 | 575 | 68 | 1.26 | $399,029 | $42,739 |
| 2019 | 78 | 434 | 71 | 1.15 | $291,525 | $30,794 |
| 2018 | 102 | 418 | 72 | 1.28 | $272,977 | $33,773 |
| 2017 | 130 | 446 | 70 | 1.22 | $274,540 | $37,290 |
| 2016 | 66 | 259 | 70 | 1.39 | $47,036 | $20,179 |
| 2015 | 38 | 163 | 69 | 1.63 | $30,875 | $15,470 |
| 2014 | 15 | 23 | 65 | 1.45 | $4,280 | $2,776 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 62 | $24,224 | $117 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 28 | $3,765 | $114 |
| New patient visit (45+ min) | 17 | $2,566 | $151 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $2,029 | $119 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $802 | $42 |
| Injection of drug or substance under skin or into muscle | 12 | $365 | $14 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 12 | $1 | None |
2022: 5 services
| Return visit (30+ min) | 63 | $28,396 | $113 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 42 | $6,420 | $117 |
| New patient visit (45+ min) | 22 | $3,238 | $147 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $1,120 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $482 | $11 |
2021: 10 services
| Return visit (30+ min) | 63 | $28,613 | $115 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $8,083 | $135 |
| New patient visit (45+ min) | 22 | $3,463 | $157 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,750 | $125 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 34 | $1,748 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 20 | $1,245 | $48 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $854 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $636 | $11 |
| Injection of drug or substance under skin or into muscle | 15 | $355 | $14 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 14 | $0 | None |
2020: 10 services
| Return visit (30+ min) | 54 | $19,094 | $99 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 23 | $4,064 | $127 |
| New patient visit (45+ min) | 21 | $3,030 | $144 |
| Short return visit (20+ min) | 25 | $2,330 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,474 | $64 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 22 | $1,093 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $777 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $415 | $11 |
| Injection of drug or substance under skin or into muscle | 16 | $309 | $14 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 11 | $0 | None |
2019: 6 services
| Return visit (30+ min) | 45 | $15,827 | $94 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 26 | $3,572 | $112 |
| Mri scan of lower spinal canal without contrast | 13 | $1,212 | $67 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 19 | $818 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 11 | $589 | $49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $437 | $11 |
2018: 6 services
| Return visit (30+ min) | 46 | $14,396 | $91 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $5,201 | $133 |
| New patient visit (45+ min) | 33 | $4,910 | $149 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $646 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 36 | $595 | $11 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 11 | $383 | $35 |
2017: 6 services
| Return visit (30+ min) | 65 | $13,935 | $92 |
| New patient visit (45+ min) | 58 | $8,048 | $139 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,320 | $129 |
| Short return visit (20+ min) | 25 | $2,025 | $65 |
| Return visit (30+ min) | 12 | $1,452 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $500 | $10 |
2016: 6 services
| New patient visit (45+ min) | 26 | $3,742 | $144 |
| Return visit (30+ min) | 22 | $3,598 | $78 |
| Return visit (30+ min) | 13 | $3,160 | $67 |
| Short return visit (20+ min) | 21 | $2,575 | $64 |
| Short return visit (20+ min) | 11 | $939 | $45 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 13 | $686 | $38 |
2015: 2 services
| Return visit (30+ min) | 27 | $7,074 | $92 |
| New patient visit (60+ min) | 13 | $2,132 | $164 |
Medicaid work
$56,744 in 2024
Medicaid paid $56,744 for 540 billed services this clinician did in 2024, up to 65 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 473 | $52,253 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 12 | $2,171 |
| Short return visit (20+ min) | 16 | $1,332 |
| Arthrocentesis and injection of knee joint | 13 | $582 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 26 | $406 |
| 2024 | 540 | 5 | 65 | $56,744 |
| 2023 | 577 | 6 | 53 | $33,237 |
| 2022 | 576 | 2 | 45 | $29,185 |
| 2021 | 583 | 3 | 56 | $24,196 |
| 2020 | 431 | 2 | 38 | $9,486 |
| 2019 | 449 | 4 | 40 | $11,072 |
| 2018 | 552 | 5 | 36 | $19,751 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 458 | $25,611 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 47 | $5,032 |
| Sign language or oral interpretive services, per 15 minutes | 28 | $1,239 |
| Arthrocentesis and injection of knee joint | 16 | $602 |
| Short return visit (20+ min) | 14 | $469 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 14 | $285 |
2022
| Return visit (30+ min) | 547 | $26,219 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 29 | $2,966 |
2021
| Return visit (30+ min) | 507 | $17,633 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 51 | $6,115 |
| Short return visit (20+ min) | 25 | $449 |
2020
| Short return visit (20+ min) | 287 | $6,083 |
| Return visit (30+ min) | 144 | $3,403 |
2019
| Return visit (30+ min) | 347 | $9,122 |
| Physician or other qualified health care professional qualified by education, training, licensure/regulation (when applicable) educational services rendered to patients in a group setting (eg, prenatal, obesity, or diabetic instructions) | 58 | $922 |
| New patient visit (45+ min) | 15 | $575 |
| Short return visit (20+ min) | 29 | $453 |
2018
| Return visit (30+ min) | 351 | $12,222 |
| Arthrocentesis and injection of knee joint | 54 | $3,143 |
| New patient visit (45+ min) | 61 | $2,928 |
| Short return visit (20+ min) | 66 | $1,139 |
| Physician or other qualified health care professional qualified by education, training, licensure/regulation (when applicable) educational services rendered to patients in a group setting (eg, prenatal, obesity, or diabetic instructions) | 20 | $320 |
Drugs they prescribed that Part D paid
$192,750
Pharmacies billed $192,750 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 40% of their Part D prescriptions (1,198 of 2,971) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 26% of their opioid prescriptions.
2,801 generic and 170 brand-name prescriptions · $192,750 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 62 | $51,385 | $829 |
| Buprenorphine | 163 | $32,852 | $202 |
| Nucynta | 14 | $18,160 | $1,297 |
| Buprenorphine-Naloxone | 46 | $12,673 | $276 |
| Suboxone | 11 | $8,592 | $781 |
See all 40 drugs
| Oxycontin | 62 | $51,385 | $829 |
| Buprenorphine | 163 | $32,852 | $202 |
| Nucynta | 14 | $18,160 | $1,297 |
| Buprenorphine-Naloxone | 46 | $12,673 | $276 |
| Suboxone | 11 | $8,592 | $781 |
| Hydrocodone-Acetaminophen | 373 | $7,759 | $21 |
| Oxycodone-Acetaminophen | 170 | $5,119 | $30 |
| Pregabalin | 159 | $4,995 | $31 |
| Movantik | 12 | $4,870 | $406 |
| Buprenorphine | 49 | $4,135 | $84 |
| Baclofen | 214 | $3,893 | $18 |
| Celecoxib | 71 | $3,874 | $55 |
| Lidocaine | 54 | $3,099 | $57 |
| Gabapentin | 275 | $2,635 | $10 |
| Oxycodone | 145 | $2,582 | $18 |
| Morphine Sulfate Er | 68 | $2,419 | $36 |
| Tizanidine | 135 | $1,622 | $12 |
| Duloxetine | 24 | $1,016 | $42 |
| Cyclobenzaprine | 105 | $769 | $7 |
| Diclofenac | 96 | $735 | $8 |
| Acetaminophen-Codeine | 57 | $622 | $11 |
| Topiramate | 64 | $617 | $10 |
| Ondansetron | 21 | $605 | $29 |
| Methadone | 14 | $590 | $42 |
| Methocarbamol | 42 | $347 | $8 |
| Tramadol | 104 | $324 | $3 |
| Ibuprofen | 25 | $252 | $10 |
| Zolpidem | 16 | $249 | $16 |
| Trazodone | 25 | $205 | $8 |
| Amitriptyline | 16 | $154 | $10 |
| Methylprednisolone | 21 | $127 | $6 |
| Carisoprodol | 25 | $118 | $5 |
| Bupropion Xl | 11 | $114 | $10 |
| Clonidine | 15 | $93 | $6 |
| Naproxen | 23 | $81 | $4 |
| Ropinirole | 15 | $73 | $5 |
| Diazepam | 77 | $69 | $1 |
| Diclofenac | 16 | $62 | $4 |
| Hydromorphone | 13 | $53 | $4 |
| Meloxicam | 14 | $46 | $3 |
Year by year
| 2024 | 2,971 | 251 | 40% (1,198) | 6% | $192,750 |
| 2023 | 2,323 | 206 | 38% (880) | 5% | $157,237 |
| 2022 | 1,855 | 180 | 37% (678) | 5% | $122,576 |
| 2021 | 1,400 | 157 | 39% (540) | 8% | $107,584 |
| 2020 | 1,268 | 141 | 36% (453) | 8% | $88,601 |
| 2019 | 1,165 | 148 | 29% (343) | 7% | $59,020 |
| 2018 | 1,036 | 166 | 26% (274) | 9% | $51,817 |
| 2017 | 798 | 128 | 28% (226) | 11% | $49,426 |
| 2016 | 539 | 93 | 38% (202) | 12% | $39,287 |
| 2015 | 391 | 83 | 38% (148) | 5% | $17,891 |
| 2014 | 117 | 41 | 13% (15) | 20% | $10,068 |
| 2013 | 21 | 13 | None | None | $3,361 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Oxycontin | 28 | $28,504 | $1,018 |
| Buprenorphine | 95 | $24,895 | $262 |
| Nucynta | 14 | $20,559 | $1,468 |
| Buprenorphine-Naloxone | 32 | $10,232 | $320 |
| Oxycodone Hcl Er | 13 | $7,653 | $589 |
| Buprenorphine | 104 | $7,449 | $72 |
| Hydrocodone-Acetaminophen | 278 | $5,646 | $20 |
| Lidocaine | 65 | $5,610 | $86 |
| Oxycodone-Acetaminophen | 158 | $5,238 | $33 |
| Gabapentin | 233 | $4,312 | $19 |
| Baclofen | 174 | $4,209 | $24 |
| Pregabalin | 87 | $3,594 | $41 |
| Oxycodone | 85 | $2,034 | $24 |
| Tizanidine | 140 | $1,757 | $13 |
| Diclofenac | 87 | $1,620 | $19 |
| Tramadol | 92 | $1,252 | $14 |
| Celecoxib | 36 | $1,149 | $32 |
| Morphine Sulfate Er | 35 | $1,119 | $32 |
| Acetaminophen-Codeine | 67 | $893 | $13 |
| Cyclobenzaprine | 66 | $719 | $11 |
| Carisoprodol | 27 | $639 | $24 |
| Ibuprofen | 48 | $637 | $13 |
| Ondansetron | 11 | $529 | $48 |
| Chlorzoxazone | 18 | $425 | $24 |
| Amitriptyline | 23 | $370 | $16 |
| Topiramate | 17 | $353 | $21 |
| Methocarbamol | 27 | $349 | $13 |
| Clonidine | 21 | $270 | $13 |
| Venlafaxine Hcl Er | 11 | $249 | $23 |
| Naproxen | 18 | $227 | $13 |
| Hydroxyzine | 14 | $196 | $14 |
| Bupropion Xl | 12 | $147 | $12 |
| Ropinirole | 14 | $73 | $5 |
| Diazepam | 41 | $38 | $1 |
2022: 28 drugs
| Oxycontin | 29 | $26,329 | $908 |
| Buprenorphine | 65 | $20,379 | $314 |
| Nucynta | 14 | $17,259 | $1,233 |
| Buprenorphine | 87 | $5,674 | $65 |
| Gabapentin | 223 | $4,945 | $22 |
| Hydrocodone-Acetaminophen | 212 | $4,882 | $23 |
| Oxycodone-Acetaminophen | 141 | $4,084 | $29 |
| Buprenorphine-Naloxone | 18 | $3,494 | $194 |
| Oxycodone | 63 | $2,777 | $44 |
| Diclofenac | 104 | $2,590 | $25 |
| Baclofen | 130 | $2,239 | $17 |
| Pregabalin | 82 | $2,209 | $27 |
| Lidocaine | 30 | $2,113 | $70 |
| Celecoxib | 53 | $1,556 | $29 |
| Tizanidine | 88 | $972 | $11 |
| Cyclobenzaprine | 83 | $955 | $12 |
| Tramadol | 75 | $789 | $11 |
| Carisoprodol | 24 | $738 | $31 |
| Topiramate | 21 | $644 | $31 |
| Meloxicam | 18 | $440 | $24 |
| Methocarbamol | 22 | $402 | $18 |
| Acetaminophen-Codeine | 47 | $357 | $8 |
| Morphine Sulfate Er | 12 | $280 | $23 |
| Methylprednisolone | 20 | $213 | $11 |
| Alprazolam | 11 | $168 | $15 |
| Ibuprofen | 21 | $144 | $7 |
| Naproxen | 13 | $84 | $6 |
| Hydroxyzine | 11 | $71 | $6 |
2021: 24 drugs
| Oxycontin | 40 | $35,437 | $886 |
| Suboxone | 17 | $12,914 | $760 |
| Buprenorphine | 28 | $9,595 | $343 |
| Buprenorphine-Naloxone | 25 | $4,587 | $183 |
| Hydrocodone-Acetaminophen | 174 | $4,026 | $23 |
| Gabapentin | 181 | $3,344 | $18 |
| Oxycodone | 68 | $3,254 | $48 |
| Oxycodone-Acetaminophen | 119 | $3,079 | $26 |
| Buprenorphine | 45 | $2,987 | $66 |
| Pregabalin | 71 | $2,348 | $33 |
| Baclofen | 121 | $2,092 | $17 |
| Diclofenac | 87 | $2,074 | $24 |
| Lidocaine | 18 | $1,381 | $77 |
| Celecoxib | 19 | $879 | $46 |
| Tizanidine | 61 | $684 | $11 |
| Carisoprodol | 13 | $428 | $33 |
| Cyclobenzaprine | 28 | $348 | $12 |
| Methocarbamol | 25 | $319 | $13 |
| Tramadol | 57 | $295 | $5 |
| Chlorzoxazone | 11 | $265 | $24 |
| Meloxicam | 18 | $220 | $12 |
| Trazodone | 13 | $207 | $16 |
| Acetaminophen-Codeine | 13 | $187 | $14 |
| Ibuprofen | 23 | $171 | $7 |
2020: 22 drugs
| Oxycontin | 31 | $27,461 | $886 |
| Suboxone | 16 | $12,735 | $796 |
| Buprenorphine-Naloxone | 29 | $7,587 | $262 |
| Buprenorphine | 21 | $7,008 | $334 |
| Oxycodone | 60 | $3,419 | $57 |
| Hydrocodone-Acetaminophen | 172 | $3,109 | $18 |
| Baclofen | 167 | $2,885 | $17 |
| Diclofenac | 103 | $2,854 | $28 |
| Lidocaine | 32 | $2,771 | $87 |
| Oxycodone-Acetaminophen | 77 | $2,635 | $34 |
| Gabapentin | 108 | $2,426 | $22 |
| Pregabalin | 41 | $1,358 | $33 |
| Tizanidine | 47 | $1,248 | $27 |
| Buprenorphine | 11 | $866 | $79 |
| Methocarbamol | 61 | $759 | $12 |
| Cyclobenzaprine | 34 | $704 | $21 |
| Carisoprodol | 19 | $551 | $29 |
| Naproxen | 14 | $318 | $23 |
| Ibuprofen | 36 | $263 | $7 |
| Tramadol | 40 | $202 | $5 |
| Trazodone | 11 | $191 | $17 |
| Acetaminophen-Codeine | 11 | $150 | $14 |
2019: 21 drugs
| Lyrica | 17 | $9,288 | $546 |
| Suboxone | 11 | $8,532 | $776 |
| Buprenorphine-Naloxone | 17 | $4,186 | $246 |
| Gabapentin | 161 | $3,591 | $22 |
| Oxycodone | 52 | $3,032 | $58 |
| Hydrocodone-Acetaminophen | 147 | $2,904 | $20 |
| Lidocaine | 26 | $2,847 | $109 |
| Baclofen | 165 | $2,572 | $16 |
| Diclofenac | 83 | $2,000 | $24 |
| Oxycodone-Acetaminophen | 62 | $1,828 | $29 |
| Cyclobenzaprine | 67 | $841 | $13 |
| Celecoxib | 14 | $605 | $43 |
| Methocarbamol | 51 | $435 | $9 |
| Carisoprodol | 12 | $368 | $31 |
| Duloxetine | 11 | $358 | $33 |
| Tizanidine | 25 | $262 | $10 |
| Ibuprofen | 22 | $239 | $11 |
| Methadone | 12 | $134 | $11 |
| Tramadol | 30 | $130 | $4 |
| Acetaminophen-Codeine | 12 | $68 | $6 |
| Trazodone | 12 | $36 | $3 |
2018: 22 drugs
| Lyrica | 18 | $9,990 | $555 |
| Butrans | 13 | $7,596 | $584 |
| Buprenorphine | 13 | $5,698 | $438 |
| Lidocaine | 35 | $3,736 | $107 |
| Baclofen | 186 | $2,683 | $14 |
| Gabapentin | 140 | $2,434 | $17 |
| Hydrocodone-Acetaminophen | 118 | $2,412 | $20 |
| Oxycodone-Acetaminophen | 53 | $1,862 | $35 |
| Oxycodone | 37 | $1,492 | $40 |
| Diclofenac | 47 | $900 | $19 |
| Duloxetine | 22 | $842 | $38 |
| Diclofenac | 14 | $774 | $55 |
| Cyclobenzaprine | 61 | $691 | $11 |
| Voltaren | 11 | $586 | $53 |
| Carisoprodol | 15 | $347 | $23 |
| Ibuprofen | 23 | $273 | $12 |
| Topiramate | 35 | $254 | $7 |
| Methocarbamol | 25 | $252 | $10 |
| Tizanidine | 21 | $221 | $11 |
| Methadone | 11 | $163 | $15 |
| Tramadol | 21 | $162 | $8 |
| Ibu | 11 | $113 | $10 |
2017: 12 drugs
| Lyrica | 28 | $17,142 | $612 |
| Oxycontin | 12 | $4,710 | $393 |
| Hydrocodone-Acetaminophen | 115 | $2,458 | $21 |
| Lidocaine | 19 | $2,200 | $116 |
| Baclofen | 91 | $2,085 | $23 |
| Gabapentin | 157 | $1,802 | $11 |
| Cyclobenzaprine | 74 | $949 | $13 |
| Oxycodone | 27 | $832 | $31 |
| Diclofenac | 39 | $653 | $17 |
| Oxycodone-Acetaminophen | 32 | $612 | $19 |
| Tizanidine | 38 | $602 | $16 |
| Tramadol | 16 | $82 | $5 |
2016: 11 drugs
| Lyrica | 44 | $15,824 | $360 |
| Lidocaine | 24 | $3,957 | $165 |
| Hydrocodone-Acetaminophen | 101 | $2,834 | $28 |
| Oxycodone-Acetaminophen | 39 | $1,520 | $39 |
| Gabapentin | 78 | $1,199 | $15 |
| Baclofen | 56 | $990 | $18 |
| Morphine Sulfate Er | 23 | $782 | $34 |
| Diclofenac | 28 | $683 | $24 |
| Oxycodone | 16 | $470 | $29 |
| Tizanidine | 12 | $194 | $16 |
| Cyclobenzaprine | 19 | $92 | $5 |
2015: 10 drugs
| Hydrocodone-Acetaminophen | 92 | $3,539 | $38 |
| Duloxetine | 25 | $3,027 | $121 |
| Lidocaine | 14 | $2,334 | $167 |
| Gabapentin | 67 | $1,750 | $26 |
| Oxycodone-Acetaminophen | 15 | $677 | $45 |
| Methadone | 17 | $584 | $34 |
| Baclofen | 36 | $466 | $13 |
| Diclofenac | 19 | $387 | $20 |
| Oxycodone | 12 | $367 | $31 |
| Cyclobenzaprine | 31 | $305 | $10 |
2014: 4 drugs
| Lyrica | 13 | $4,822 | $371 |
| Lidocaine | 12 | $1,455 | $121 |
| Gabapentin | 28 | $778 | $28 |
| Cyclobenzaprine | 11 | $180 | $16 |
Money from drug and device companies
$80 in 2025
| 2025 | 2 | 2 | None | $80 |
| 2022 | 1 | 1 | None | $81 |
| 2019 | 1 | 1 | None | $30 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $54 | 1 payment
|
| Medtronic | Kyphon Express II Kyphopak Tray | $26 | 1 payment
|
See all 2 published payments
| Medtronic | Education · 2025-05-28 | Kyphon Express II Kyphopak Tray | $26 |
| Vertex Pharmaceuticals | Meals · 2025-04-05 | Journavx | $54 |
See earlier years (2022, 2019)
2022: $81
| Indivior | Sublocade | $81 | 1 payment
|
2019: $30
| DePuy Synthes Sales | Im Nails | $30 | 1 payment
|
Professional record
- NPI
- 1710114772
- Licence
- CA A116395California A116395: Current · expires 2027-04-30
- Trained
- University of Cincinnati College of Medicine, 2009
- Group
- Spine and Sports Medical Group Inc · County of San Mateo
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 208VP0000X (208VP0000X); Federal specialty code 208VP0014X (208VP0014X)
- Mailing address
- 300 Berry St Unit 813, San Francisco, CA, 94158
- NPI first listed
- 2009-06-17
- NPI last updated
- 2025-10-31
- NPI record certified
- 2025-10-31
This is when the NPI record was last certified, not a medical board exam.